Over 12 months, Precision Biosciences Inc saw more selling than buying from its insiders — purchases of about $63,000 against sales of $466,000.
Germano Geno J (Director) made the biggest buy, worth around $16,000.
Big money check: 95 institutions held DTIL as of Q2 2026, and more funds bought than sold. Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 5 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Frankel Stanley | Director | Buy | 1,000 | $6.00 | $6K | SEC |
| Sep 29, 2026 | Brown Melinda | Director | Buy | 1,135 | $6.27 | $7K | SEC |
| Sep 29, 2026 | Germano Geno J | Director | Buy | 2,609 | $6.28 | $16K | SEC |
| Feb 19, 2026 | Amoroso Michael | CEO | Sell | 20,559 | $3.84 | $79K | SEC |
| Feb 19, 2026 | Kelly John Alexander | CFO | Sell | 8,149 | $3.84 | $31K | SEC |
| Feb 19, 2026 | Scimeca Dario | Executive Officer | Sell | 4,925 | $3.84 | $19K | SEC |
| Feb 19, 2026 | SMITH J. JEFFERSON | Executive Officer | Sell | 4,925 | $3.84 | $19K | SEC |
| Jan 22, 2026 | Amoroso Michael | CEO | Sell | 34,799 | $4.17 | $145K | SEC |
| Jan 22, 2026 | Scimeca Dario | Executive Officer | Sell | 8,854 | $4.03 | $36K | SEC |
| Jan 22, 2026 | Kelly John Alexander | CFO | Sell | 15,213 | $4.03 | $61K | SEC |
| Jan 22, 2026 | SMITH J. JEFFERSON | Executive Officer | Sell | 10,200 | $4.03 | $41K | SEC |
| Dec 17, 2025 | Germano Geno J | Director | Buy | 3,000 | $4.72 | $14K | SEC |
| Dec 17, 2025 | Frankel Stanley | Director | Buy | 2,700 | $4.70 | $13K | SEC |
| Dec 17, 2025 | Brown Melinda | Director | Buy | 1,381 | $4.97 | $7K | SEC |
| Nov 4, 2025 | Amoroso Michael | CEO | Sell | 3,409 | $6.49 | $22K | SEC |
In the last 12 months Precision Biosciences Inc insiders made open-market purchases worth about $63,000 and sales worth about $466,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in DTIL was filed on 2026-09-30.
95 investment managers reported holding DTIL in SEC Form 13F filings for Q2 2026.
No congressional trades in DTIL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).